Trodelvy 180 mg lyophilized powder for injection Images
Generic Name: sacituzumab govitecan
This medication has been identified as Trodelvy 180 mg lyophilized powder for injection. It is supplied by Gilead Sciences, Inc.
Trodelvy is used in the treatment of Breast Cancer; Urothelial Carcinoma and belongs to the drug class miscellaneous antineoplastics. Trodelvy 180 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Trodelvy
- Generic Name
- sacituzumab govitecan
- Strength
- 180 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 55135-0132
More about Trodelvy (sacituzumab govitecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
